Stroke Trial, Recruiting NCT04800913 Sponsor: Hungarian Institute of Cardiology Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04800913
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a medical reason to have a left atrial appendage closure (a procedure to close off a small pouch in the heart) and are having this procedure done at Gottsegen National Cardiovascular Center between 10 March 2021 and 31 December 2025
  • People aged 18 years or older
  • People who have given their informed consent to take part
  • People who have the legal capacity to make their own decisions

Who may not be able to join:

  • People under 18 years of age
  • People who are pregnant
  • People who have been legally determined to lack decision-making capacity
  • People who have not given consent to participate
  • People who have a narrowing or an abnormal pouch in the esophagus (the tube connecting the throat to the stomach)
  • People who have active bleeding in the esophagus
  • People who have an allergy to the dye used in CT scans (contrast agent)
  • People with severe chronic kidney disease (where the kidneys are functioning at a very low level)
  • People who have a blood clot in the left atrial appendage (the area of the heart the procedure targets) that is mobile or considered high risk
  • People whose life expectancy is less than 12 months
  • People with an active infection
  • People with significant narrowing of the mitral heart valve
  • People who have a mechanical (artificial) heart valve
  • People for whom open heart surgery has been recommended

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anita Zadori, MD, PhD, 0036303837011, anita.zadori@gokvi.hu

Phone: 0036703820470

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hungarian Institute of Cardiology
Registry
ClinicalTrials.gov
Start date
8 November 2021
Est. completion
31 December 2028

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Effective radiation dose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov